FindTrial
Sign In

The clinical application of the perioperative temporary balloon occlusion of the internal iliac arteries followed by uteme artery embolization in the treatment of placenta increta

The clinical application of the perioperative temporary balloon occlusion of the internal iliac arteries followed by uteme artery embolization in the treatment of placenta increta

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17013770
Enrollment
Unknown
Registered
2017-12-08
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placenta increta

Interventions

ballon placement and embolization (A):ballon placement and artery embolization

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Placenta increra patient and her infant

Exclusion criteria

Exclusion criteria: 1. Severe contrast agent allergy; 2. Uncorrectable coagulopathy; 3. Renal insufficiency.

Design outcomes

Primary

MeasureTime frame
amount of bleeding;blood transfusion;puerperal infection;Ischemia pain;thrombogenesis;Late ovarian function;—

Secondary

MeasureTime frame
Gestational weeks of birth;Apgar score;—

Countries

China

Contacts

Public ContactLiu Yan

Tianjin First Central Hospital

liuyan619@yahoo.com13662121425

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026